CREBZF expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.44009282066327E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.33142410827259E-12 |
Normal-vs-Stage2 |
5.99059999999429E-05 |
Normal-vs-Stage3 |
1.52399999997499E-06 |
Normal-vs-Stage4 |
4.27400000000411E-05 |
Stage1-vs-Stage2 |
3.364400E-01 |
Stage1-vs-Stage3 |
6.960800E-01 |
Stage1-vs-Stage4 |
3.399400E-01 |
Stage2-vs-Stage3 |
2.401200E-01 |
Stage2-vs-Stage4 |
1.374030E-01 |
Stage3-vs-Stage4 |
5.968000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.59914312294995E-12 |
Normal-vs-AfricanAmerican |
7.05789999777551E-08 |
Normal-vs-Asian |
9.958100E-03 |
Caucasian-vs-AfricanAmerican |
2.004600E-03 |
Caucasian-vs-Asian |
1.444170E-01 |
AfricanAmerican-vs-Asian |
8.622200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.38149558038504E-11 |
Normal-vs-Female |
2.03037586743449E-12 |
Male-vs-Female |
3.514000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.291700E-02 |
Normal-vs-Age(41-60Yrs) |
1.7178480860025E-12 |
Normal-vs-Age(61-80Yrs) |
5.71239999747064E-09 |
Normal-vs-Age(81-100Yrs) |
1.230120E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.274800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.639600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.516400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.992400E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.776600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.235200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.635540E-04 |
Normal-vs-Grade 2 |
1.99729122130066E-12 |
Normal-vs-Grade 3 |
1.55989998695816E-09 |
Normal-vs-Grade 4 |
1.031590E-02 |
Grade 1-vs-Grade 2 |
1.090180E-01 |
Grade 1-vs-Grade 3 |
3.956000E-03 |
Grade 1-vs-Grade 4 |
5.151000E-04 |
Grade 2-vs-Grade 3 |
4.188200E-02 |
Grade 2-vs-Grade 4 |
1.664620E-03 |
Grade 3-vs-Grade 4 |
8.975800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.65067959301268E-12 |
Normal-vs-ccB subtype |
1.633020E-04 |
ccA subtype-vs-ccB subtype |
7.73809999999875E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.17390550005803E-11 |
Normal-vs-N1 |
4.690000E-01 |
N0-vs-N1 |
1.016390E-01 |
|
|